Expertise in
7
conditions

Dr. David Y. Lee

Radiation Oncology
Office
800 Bradbury Dr SE Ste 116, 
Albuquerque, NM 
Accepting New Patients
Expertise in
7
conditions
Office
800 Bradbury Dr SE Ste 116, 
Albuquerque, NM 

Overview

David Lee is a Radiation Oncologist practicing medicine in Albuquerque, New Mexico.

Dr. Lee is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Pleuropulmonary Blastoma, Lung Cancer, and Familial Pancreatic Cancer.

He is actively involved in clinical research, co-authoring 4 peer reviewed articles and participating in 9 clinical trials. Dr. Lee is currently accepting new patients.

Specialties

Radiation Oncology

Licenses

Radiology in NM

Hospital Affiliations

Unm Hospital

Languages Spoken

English
Spanish

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 4 Less Insurance Carriers -

Locations

Office
800 Bradbury Dr SE Ste 116, Albuquerque, NM 87106
Other Locations
Cancer Center Pharmacy
Albuquerque, NM 87102

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women With Early Breast Cancer
Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women With Early Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: September 02, 2026
Intervention Type: Other
Study Phase: Phase 3
A Phase III Randomized Study of Maintenance Nivolumab Versus Observation in Patients With Locally Advanced, Intermediate Risk HPV Positive OPSCC
A Phase III Randomized Study of Maintenance Nivolumab Versus Observation in Patients With Locally Advanced, Intermediate Risk HPV Positive OPSCC
Enrollment Status: Active_not_recruiting
Publish Date: August 04, 2026
Intervention Type: Procedure, Drug, Biological, Radiation, Other
Study Drugs: Cisplatin, Nivolumab
Study Phase: Phase 3
A Phase IIR/III Trial of Standard of Care Therapy With or Without Stereotactic Body Radiotherapy (SBRT) and/or Surgical Ablation for Newly Oligometastatic Breast Cancer
A Phase IIR/III Trial of Standard of Care Therapy With or Without Stereotactic Body Radiotherapy (SBRT) and/or Surgical Ablation for Newly Oligometastatic Breast Cancer
Enrollment Status: Completed
Publish Date: July 10, 2026
Intervention Type: Radiation, Procedure
Study Phase: Phase 2/Phase 3
A Randomized Phase II/III Trial of De-Intensified Radiation Therapy for Patients With Early-Stage, P16-Positive, Non-Smoking Associated Oropharyngeal Cancer
A Randomized Phase II/III Trial of De-Intensified Radiation Therapy for Patients With Early-Stage, P16-Positive, Non-Smoking Associated Oropharyngeal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 02, 2026
Intervention Type: Other, Procedure, Drug, Biological, Radiation
Study Drugs: Cisplatin, Nivolumab
Study Phase: Phase 2/Phase 3
A Phase II Randomized Trial of Olaparib (NSC-747856) Administered Concurrently With Radiotherapy Versus Radiotherapy Alone for Inflammatory Breast Cancer
A Phase II Randomized Trial of Olaparib (NSC-747856) Administered Concurrently With Radiotherapy Versus Radiotherapy Alone for Inflammatory Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 02, 2026
Intervention Type: Drug, Procedure, Radiation, Other
Study Drug: Olaparib
Study Phase: Phase 2
TAILOR RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
TAILOR RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 01, 2026
Intervention Type: Radiation, Other
Study Phase: Phase 3
A Phase III Prospective Randomized Trial of Acupuncture for Treatment of Radiation-Induced Xerostomia in Patients With Head and Neck Cancer
A Phase III Prospective Randomized Trial of Acupuncture for Treatment of Radiation-Induced Xerostomia in Patients With Head and Neck Cancer
Enrollment Status: Completed
Publish Date: February 27, 2026
Intervention Type: Other
Study Phase: Not Applicable
RT CHARM: Phase III Randomized Trial of Hypofractionated Post Mastectomy Radiation With Breast Reconstruction
RT CHARM: Phase III Randomized Trial of Hypofractionated Post Mastectomy Radiation With Breast Reconstruction
Enrollment Status: Active_not_recruiting
Publish Date: February 24, 2026
Intervention Type: Other, Radiation
Study Phase: Phase 3
Single Center, Phase II Study of Whole Brain Radiation Using IMRT to Spare the Hippocampus While Delivering Differential Doses to Subclinical Sites Versus Gross Disease for Treatment of Patients With Brain Metastases
Single Center, Phase II Study of Whole Brain Radiation Using IMRT to Spare the Hippocampus While Delivering Differential Doses to Subclinical Sites Versus Gross Disease for Treatment of Patients With Brain Metastases
Enrollment Status: Completed
Publish Date: May 22, 2025
Intervention Type: Radiation
Study Phase: Not Applicable
View 8 Less Clinical Trials

4 Total Publications

Editorial: Reviews in radiation oncology.
Editorial: Reviews in radiation oncology.
Journal: Frontiers in oncology
Published: August 26, 2023
Similar Doctors
Expertise in
17
conditions
Dr. Thomas M. Schroeder
Radiation Oncology
Expertise in
17
conditions
Dr. Thomas M. Schroeder
Radiation Oncology
Referral may be required

Office

800 Bradbury Dr SE Ste 116, 
Albuquerque, NM 
 (0.1 miles away)
Languages Spoken:
English, Spanish
See accepted insurances
Offers Telehealth

Thomas Schroeder is a Radiation Oncologist practicing medicine in Albuquerque, New Mexico. Dr. Schroeder is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, Lung Cancer, and Pleuropulmonary Blastoma.

Expertise in
16
conditions
Dr. Benny J. Liem
Radiation Oncology
Expertise in
16
conditions
Dr. Benny J. Liem
Radiation Oncology
Referral may be required

University Of New Mexico Ems Consortium

1 University Of New Mexico, 
Albuquerque, NM 
 (2.0 miles away)
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Benny Liem is a Radiation Oncologist practicing medicine in Albuquerque, New Mexico. Dr. Liem is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Posterior Fossa Tumor, Radiation Induced Meningioma, Meningioma, and Astrocytoma. Dr. Liem is currently accepting new patients.

Expertise in
1
conditions
Dr. Robert R. Kuske
Radiation Oncology
Expertise in
1
conditions
Dr. Robert R. Kuske
Radiation Oncology
Referral may be required

New Mexico Oncology Hematology Consultants LTD.

4901 Lang Ave NE, 
Albuquerque, NM 
 (8.2 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Robert Kuske is a Radiation Oncologist practicing medicine in Albuquerque, New Mexico. Dr. Kuske is highly rated in 1 condition, according to our data. His clinical expertise encompasses Breast Cancer, Intraductal Papilloma, Pleuropulmonary Blastoma, and Lung Cancer. Dr. Kuske is currently accepting new patients.

Frequently Asked Questions about Dr. David Y. Lee

How do I make an appointment with Dr. David Y. Lee?

You can book an appointment with Dr. David Y. Lee by calling their office at 505-272-4946. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. David Y. Lee a top-rated expert for Laryngeal Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. David Y. Lee is classified as an Advanced expert for Laryngeal Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. David Y. Lee specialize in?

While Dr. David Y. Lee is a Radiation Oncology, they have specific expertise in Laryngeal Cancer, Pleuropulmonary Blastoma, and Lung Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.

Does Dr. David Y. Lee participate in research or clinical trials?

Yes. Dr. David Y. Lee has published 4 articles and abstracts on conditions like Laryngeal Cancer. You can view a list of Dr. David Y. Lee's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. David Y. Lee accept my insurance?

Dr. David Y. Lee accepts most major insurance plans, including Aetna and Cigna. We recommend calling the office directly at 505-272-4946 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Lee's expertise for a condition
ConditionClose
      View All 7 Advanced Conditions
      View All 80 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile